Advertisement

Topics

CureVac AG Company Profile

12:44 EDT 24th April 2018 | BioPortfolio

CureVac is a leading company in the field of messenger RNA (mRNA) technology with more than 17 years’ expertise in handling and optimizing this versatile molecule for medical purposes. The principle of CureVac's proprietary technology is the use of mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases. The company applies its technologies for the development of cancer therapies, prophylactic vaccines and molecular therapies.


News Articles [18 Associated News Articles listed on BioPortfolio]

CureVac to Pursue mRNA Vaccines Against Flu and Malaria

CureVac AG announced the awarding of two new grants from the Bill & Melinda Gates Foundation. The programs will leverage CureVac’s RNActive® prophylactic vaccine technology to develop mRNA-based va...

Bill & Melinda Gates Foundation shows faith in CureVac

The Bill & Melina Gates Foundation had already invested $52 million in CureVac, back in 2015, and has now doubled down on its investment, as the biotech announced that the foundation had boosted i...

CureVac to Present at the 2018 J.P. Morgan 36th Annual Healthcare Conference

CureVac AG, a clinical-stage biopharmaceutical company pioneering mRNA-based drugs, will present at the 2018 J.P. Morgan 36th Annual Healthcare Conference to be held January 8-12,...

Germany's CureVac wins new vaccine funding from Gates Foundation

(Reuters) - German biotech firm CureVac has secured more financial backing for vaccine development projects from its investor the Bill & Melinda Gates Foundation, working on jabs to prevent malaria an...

Bill Gates foundation awards grants to mRNA vaccine developer CureVac

CureVac, a biopharmaceutical company focused on developing mRNA-based drugs, has been awarded two new grants from the Bill & Melinda Gates Foundation.

CureVac and Arcturus Therapeutics announce broad strategic collaboration

CureVac AG and Arcturus Therapeutics Ltd. announced they have entered into a broad strategic collaboration to jointly discover, develop and commercialize novel messenger RNA (mRNA) therapeutics. Under...

CureVac and Arcturus Collaborate to Advance Next Generation of Lipid-Mediated mRNA Therapeutics

TÜBINGEN, Germany & BOSTON & SAN DIEGO–(BUSINESS WIRE)–CureVac AG, a leading clinical-stage biopharmaceutical company focused on the development of pioneering mRNA therapeutics, a...

Gates-Stiftung gibt neue Finanzspritze: Microsoft-Gründer Bill Gates will mit der Biotechfirma Curevac ...

Microsoft-Gründer Bill Gates will mit der Biotechfirma Curevac Impfstoffe gegen Malaria und Grippe entwickeln. Jetzt gibt er das dazu nötige Kapital.Der Microsoft-Gründer Bill Gates steckt weiteres...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

CureVac AG

CureVac is a leading company in the field of messenger RNA (mRNA) technology with more than 17 years’ expertise in handling and optimizing this versatile molecule for medical...

The International mRNA Health Conference

The International mRNA Health Conference brings together top scientists and professionals from all around the world to discuss the rapidly growing field of mRNA while fostering or...

CureVac GmbH

We are dedicated to offering reliable and innovative RNA related products and services to the Life Science Community. siRNA [order here]: ultrapure (HPLC purified)For the design of siRNA please use EM...

More Information about "CureVac AG" on BioPortfolio

We have published hundreds of CureVac AG news stories on BioPortfolio along with dozens of CureVac AG Clinical Trials and PubMed Articles about CureVac AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CureVac AG Companies in our database. You can also find out about relevant CureVac AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record